observation of FDC pedigrees in which not all affected individuals carry the putative disease-causing LMNA mutation 23 suggests that some protein-altering LMNA variants are not causative or that some proportion of FDC may be because 24 of multiple causative factors. These findings warrant increased caution in FDC research and molecular diagnostics. of LMNA mutations remains unclear.
60
The purpose of this study was 2-fold-to better 
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included 324 unrelated IDC probands and used methods of 69 clinical categorization previously described. 10 For this study,
70
families with confirmed and probable familial disease 10 Foster City, CA) and analyzed by capillary electrophoresis on an Mutations in LMNA and the lamin A and C proteins and amino acid conservation. A, The LMNA gene is shown. Lamin A (shown below) is coded by exons 1 to 12 and is a total of 664 amino acids in length. Lamin C (above) is coded by exons 1 to 9 and an alternatively spliced exon 10 and is 572 amino acids long. The locations of the 18 mutations are labeled with their respective letters. B, Sequencing electropherograms show heterozygosity for each mutation labeled A through S. The nucleotide changes and their effects on amino acid sequence are indicated. X, Stop; fs, frame shift; del, deletion; ins, insertion. All amino acids changed by mutations were conserved across mouse, rat, chicken, and zebrafish except for mutation D/E and R (mouse, rat, and chicken) and mutation O (mouse, rat). C, SIFT
17

Q4
or Polyphen 18 data are shown for missense mutations.
D, Sequence data show skipping of LMNA exon 2 for mutation C. The 357-1GNT splice site mutation results in a minor PCR product representing a transcript in which exon 3 follows immediately after exon 1. and muscle LIM protein (CSRP3).
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Results
134
Molecular analysis of the FDC cohort
135
The entire coding region of LMNA ( Figure 1 insertion, 1 splice site, and 1 deletion variant (Table I) .
144
Seventeen variants in 18 probands were predicted to ted exclusion of CAD were given "unknown" status.
160
Others given "unknown" status were those with either 161 LVE or systolic dysfunction (but not both) or conduction 162 system disease or arrhythmias without DCM. In family C, the identified mutation affected the splice Pedigrees A, C, D, E, F, H, K, M, Q, and R. Pedigrees have been labeled by letter, which correspond to their respective mutation as shown in Figure 1 . Squares represent males; circles, females. An arrowhead denotes the proband. A diagonal line marks deceased individuals. Solid symbols indicate IDC with or without heart failure, shaded symbols represent any cardiovascular abnormality. Open symbols represent unaffected individuals. The presence or absence of the familial LMNA mutation is indicated by a + or − symbol, respectively. Obligate carriers are noted in parenthesis (+). Available clinical data are provided under the symbols. The first line is the current age or age of death, followed by the age of onset in parenthesis, and the current major medical diagnosis if alive, or the cause of death if known. Age at cardiac transplantation, when applicable, is the second line. The next line describes LV size and function; z score is the SD from the mean of the left ventricular end-diastolic dimension measured by echocardiography. The ejection fraction follows; where values are not available, descriptive terms are provided. The last line describes arrhythmias and/or conduction system disease. Afib, Atrial fibrillation; Asym, asymptomatic; Arr, arrhythmia; ASHD, atherosclerotic heart disease; AV, atrioventricular; AVB atrioventricular block; 1AVB or 2AVB, first-degree or second-degree AVB, respectively; A/W, alive and well; bigem, bigeminy; Bi-F, bifascicular block; BiV-ICD; biventricular pacemaker with implantable cardiac defibrillator; Br, bradycardia; CHD, congenital heart disease; CM, cardiomyopathy, unknown type; CVA, cerebrovascular accident; CVD, cardiovascular disease; EF, ejection fraction; enl hrt, enlarged heart; Htn, hypertension; HtTr, heart transplant; ICD, implantable cardiac defibrillator; IRBBB, incomplete right bundle branch block; irreg, irregular; HB, heart beat; LBBB, left bundle branch block; Nl scr, normal cardiovascular screening; NSR, normal sinus rhythm; NSSTT, nonspecific ST-T changes on ECG; NSVT, nonsustained ventricular tachycardia; occ, occasional; PAC, paroxysmal atrial contractions; PM, pacemaker; PVCs, premature ventricular contractions; RBBB, right bundle branch block; SCD, sudden cardiac death; tachy, sinus tachycardia; SSS, sick sinus syndrome; VT, ventricular tachycardia; Z, z score. 
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In an effort to identify an additional disease-causing 
